bioAffinity Technologies, Inc. (BIAF)

bioAffinity Technologies Revenue

bioAffinity Technologies had revenue of $1.07M in the quarter ending September 30, 2026, a decrease of -25.99%. This brings the company's total for the last twelve months to $5.53M, down -18.47% year-over-year. In the year 2025, bioAffinity Technologies had annual revenue of $6.16M, down -34.18%. That makes bioAffinity Technologies the 39,649th largest company in the world by revenue and 5,246th in the United States.

• Revenue (ttm): $5.53M
• Revenue Growth: -18.47%
• P/S Ratio: 0.58
• Revenue / Employee: $96,933
• Employees: 57
• Market Cap: 3.11M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Laboratory Services 6.16M 100.0%
• Diagnostic R&D 577.00 0.0%

Fiscal year ended Dec 31, 2025 See the full bioAffinity Technologies breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.16M	-3.20M	-34.18%
Dec 31, 2024	9.36M	6.83M	269.68%
Dec 31, 2023	2.53M	2.53M	52,627.44%
Dec 31, 2022	4.80K	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Nov 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error